Justin D. Pearlman, MD, PhD, FACC – Scientific Expert & Key Opinion Leader on Cardiovascular Diseases, Cardiac Imaging & Complex Diagnosis in Cardiology: Senior Editor & Author | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Justin D. Pearlman, MD, PhD, FACC – Scientific Expert & Key Opinion Leader on Cardiovascular Diseases, Cardiac Imaging & Complex Diagnosis in Cardiology: Senior Editor & Author

Justin D. Pearlman MD PhD – Scientific Expert & Key Opinion Leader on Cardiovascular Diseases, Cardiac Imaging & Complex Diagnosis in Cardiology: Senior Editor & Author

Justin D. Pearlman, AB, MD, ME, PhD, MA, FACC

jdpmdphd@gmail.com

C 617-894-6888

UPDATED 11/9/2020

Selected Projects

Speaking on, 10/10, 11/10 at Noon – Global Zoom

Is OVERDUE in submission of Top 16 CVD articles in the Journal from list of All articles with +2,000 views
NEEDS to define AI in Cardiac Imaging Specialty for 2.0 LPBI for Health care Insurer in UT
Podcast with Gail

Specialties:

Internal Medicine
Cardiology
Cardiovascular Radiology
Image Processing
Computer Science
Electronic Records

BIO

Dr. Pearlman holds degrees of MD from UCHC 1980, ME at University of Virginia (Biomedical Engineering) 1985, and PhD, University of Virginia (Engineering, Applied Sciences) 1986, plus an honorary Master of Arts from Dartmouth. His PhD work discovered the liquid crystal nature of atherosclerosis, and pioneered MRI and ESR methods for its detection and characterization including identifying the major role of body temperature changes and triglycerides in the change of state that causes vessel damage. He completed a Cardiology Fellowship at University of Virginia 1983-1986, with NIH Research Fellowship in 1985-1986 and Fellow in Noninvasive Imaging: Department of Medicine, Cardiac Unit at Massachusetts General Hospital in Boston, MA 1987, and a fellowship in Geriatrics and Leadership at UCLA 2014.

In the pursuit of his 2 degrees in biomedical engineering and applied sciences, he developed skills and experience for designing projects and team building that generated highly productive multidisciplinary collaborations. Specifically, he worked productively with Cardiology, Anesthesiology, Emergency Medicine, Molecular Biology, Oncology, Internal Medicine, Radiology, and Surgery, plus basic science departments including Biochemistry and Molecular Biology, Pharmacology and Toxicology, Mathematics, Statistics, Physiology and Biophysics, and Business as well as other Schools, and was promoted to full Professor in Medicine, Radiology, Biomedical Engineering and Computer Science.

He serves as Editor for E-Medicine and for Leaders in Pharmaceutical Intelligence (LPBI) Group’s Open Access Online Scientific Journal http://pharmaceuticalintelligence.com, including a three volume theme of e-Books on Cardiovascular Causes, Diagnosis, https://lnkd.in/e6WkMgF

In addition, management and grant reviewer for multiple agencies including NIH and AHA.

He sponsored numerous PhD’s and MD’s in cardiovascular clinical excellence and efficiency, generating and fostering basic research and bench-to-bedside translational research. His breadth of experiences includes funding and directing a supercomputer facility, funding, designing and building advanced cardiovascular imaging centers. He designed and directed a supercomputer facility and advanced imaging centers with MRI, CT, PET, marked by 23 patent claims, and over 4,000 citations in scientific peer-reviewed literature. His supervisory roles include chief of cardiology, vice-chair and chair of Medicine, directorships in engineering, computer science, magnetic resonance, advanced imaging and medicine, hiring, remediating, program development, team building, designing and providing training at advanced levels (including founding and teaching advanced coursework at MIT and Harvard).

HONORS:

1971 John Harvard Scholar
1972-1975 Harvard College Scholarship for High Standing on the Dean’s List
1975 High Honors in Mathematics, Harvard University
1975 Rodgers Prize in Mathematics, Harvard University
(Invented Singularity Point Editing, proved converse to Hopf Poincaré Index Theorem)
1976-1980 Joseph Collins Scholarship for Marked Excellence in Scholastic and Extracurricular Activities
1986 Young Investigators Award (Finalist), American College of Cardiology He invented an NMR method of P-31 of ischemic metabolism evaluation for that award, and subsequently invented methods for microvascular imaging and non-invasive MRI of myocardial oxygenation cycling.
1988-1993 F.I.R.S.T. Awardee, National Institutes of Health (R29 HL41287)(Discovered liquid crystal behavior of atheroma lipid and developed methods to characterize triglyceride salting of the transition to solidification, invented diffusion imaging, invented maximum projection angiography, first myocardial scar map, first myocardial tagging, invented velocity beam real-time CMR)
1993- Listed in Best Physicians in America (both under Radiology and Cardiology)
Invented/pioneered diffusion imaging myocardial tagging, intensity projection angiography, and distortion-free MRI electrocardiography
1996- Listed in Best Physicians in New England
1997- Listed in Best 2,000 Physicians in America (both under Radiology and Cardiology)
1997- Fellow, American College of Cardiology
1999- Listed in Best of Boston, Who’s Who in the World, Who’s Who among
Professionals, Who’s Who among Administrators

Curriculum Vitae

SCIENCE Side Member

Responsibilities @2.0 LPBI:

(1) Curator initiated new content creation

(2) Updates to own published articles in the Journal

(3) Commissions by the Editor-in-Chief

(4) Client facing engagement with External relations & Monthly Global Zoom Meetings

(5) Advice for the Founder: voluntarily and per request

Roles on 2.0 LPBI Group’s TNS #1,2,3,4,5,6

https://pharmaceuticalintelligence.com/vision/

TNS #1: TEXT Analysis on our CARDIOVASCULAR contents: NLP, ML, AI – INSIGHTS MEAN VALUE and Up-selling content

Phase 1: Proof of Concept for 16 articles on Cardiovascular Diseases viewed >2,000
Phase 2: Scale up to SIX volumes on Cardiovascular Diseases

https://lnkd.in/e6WkMgF

Phase 3: Scale up to all articles in all CVD categories of Research in the Journal

PUBLICATIONS in Open Access Online Scientific Journal

https://pharmaceuticalintelligence.com/

Series A: e-Books on Cardiovascular Diseases – Six Volumes

Cardiovascular Diseases, Volume One: Perspectives on Nitric Oxide in Disease Mechanisms. On com since 6/21/2013 https://lnkd.in/8DANfq
Cardiovascular Diseases, Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation. On com since 11/30/2015 https://lnkd.in/ekbuNZ3
Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. On com since 11/29/2015 https://lnkd.in/ecp5mrA
Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases. On com since 12/26/2015 https://lnkd.in/dwqM3K3
Cardiovascular Diseases, Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases. On com since 12/23/2018 https://lnkd.in/e3r87cQ
Cardiovascular Diseases, Volume Six: Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment. On com since 12/24/2018 https://lnkd.in/e_CTb4R